<DOC>
	<DOCNO>NCT01171300</DOCNO>
	<brief_summary>Rectal cancer frequent curable malignancy Western world . The golden standard treat patient consist neoadjuvant chemoradiotherapy ( CRT ) follow extensive surgery regardless tumor response . The main question whether extensive surgery avoid hold mind already significant amount patient reach pathological complete response radiochemotherapy . The goal study dual . First , investigator want investigate value DW-MRI 18FDG-PET assessment response neoadjuvant CRT 100 patient rectal cancer , select patient eligible less invasive surgery . In patient group , investigator examine biomarker potential molecular characteristic tumor blood tissue . Using molecular radiological finding , investigator want predict pathological response chemoradiotherapy select patient may benefit treatment adjustment chemoradiotherapy .</brief_summary>
	<brief_title>Assessment Response Before , During After Neoadjuvant Chemoradiotherapy Rectal Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Patient least 18 year age . Patient 's body weight ≤ 120 kg . Histologically proven evaluable ( accord RECIST criterion ) adenocarcinoma rectum ( tumour &lt; 15 cm anal verge ) , stag T34 N0 T14N12 . WHO PS ≤ 2 Adequate bone marrow , hepatic renal function ( assess within 14 day prior study entry ) : Hemoglobin &gt; 10.0 g/dL , Absolute neutrophil count &gt; 1.5 x 109/L , Platelet count &gt; 100 x 109/L , Presence adequate contraception fertile patient . Adequate method contraception : intrauterine device , hormonal contraception , condom use spermicide . Written informed consent must give accord ICH/GCP national/local regulation . Evidence distant metastasis . Prior chemotherapy radiotherapy rectal cancer . Pregnant breastfeed woman . Significant impairment intestinal resorption ( e.g . chronic diarrhea , inflammatory bowel disease ) . Known allergy intravenous contrast agent . Contraindications magnetic resonance imaging ( metal implant , claustrophobia , etc . ) . Previous concurrent malignancy sit exception surgically cure adequately treat carcinoma insitu cervix nonmelanoma skin cancer . History uncontrolled seizure , central nervous system disorder psychiatric disability judge investigator clinically significant precluding inform consent interfere compliance oral drug intake . Presence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule ; condition discuss patient registration trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>stag T3-4 N0 T1-4N1-2</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>rectum</keyword>
</DOC>